Percutaneous Image Guided Video-Assisted Thoracic Surgery (VATS) Resection of Lung Lesions
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01847209|
Recruitment Status : Unknown
Verified February 2015 by Raphael Bueno, Brigham and Women's Hospital.
Recruitment status was: Active, not recruiting
First Posted : May 6, 2013
Last Update Posted : February 24, 2015
|Condition or disease||Intervention/treatment||Phase|
|Lung Cancer||Procedure: Video-Assisted Thoracic Surgery (VATS) wedge resection||Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||25 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Percutaneous Image Guided Video Assisted Thoracic Surgery (VATS) Resection of Lung Lesions|
|Study Start Date :||April 2013|
|Actual Primary Completion Date :||September 2014|
|Estimated Study Completion Date :||December 2015|
Experimental: CT Marking and VATS lung wedge resection
Each patient with a lung nodule meeting criteria will undergo marking with fiducials followed at the same time by Video-Assisted Thoracic Surgery (VATS) lung wedge resection under CT fluoroscopy.
Procedure: Video-Assisted Thoracic Surgery (VATS) wedge resection
Other Name: Nodules marked with fiducials such as Kopan needles under CT fluoroscopy followed by VATS wedge resection.
- Safety [ Time Frame: 30 days ]The patient will be monitored while in the hospital by their thoracic surgical team as well as by two research nurses named Lauren Donahue, RN and Karen Magsipoc, NP. The research nurses will document any perioperative complications and mortality that arise during the patient's stay in the hospital.
- Efficacy [ Time Frame: 30 days ]Accurate and appropriate resection in a given timeline
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01847209
|United States, Massachusetts|
|Brigham and Women's Hospital|
|Boston, Massachusetts, United States, 02115|
|Principal Investigator:||Raphael Bueno, M.D.||Brigham and Women's Hospital|